Shares of Genus plc (LON:GNS) have been given a consensus recommendation of “Buy” by the seven brokerages that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is GBX 3,082.83 ($40.28).

Several analysts have recently weighed in on the stock. Peel Hunt restated a “buy” rating and set a GBX 3,200 ($41.81) price objective on shares of Genus in a research report on Thursday, November 14th. Peel Hunt restated a “buy” rating on shares of Genus in a report on Wednesday, November 20th. Jefferies Financial Group began coverage on shares of Genus in a research report on Friday, November 15th. They issued a “hold” rating and a GBX 3,272 ($42.75) target price on the stock. HSBC lifted their price target on shares of Genus from GBX 3,000 ($39.20) to GBX 3,260 ($42.60) and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Finally, Liberum Capital boosted their price target on shares of Genus from GBX 2,800 ($36.59) to GBX 3,450 ($45.08) and gave the company a “buy” rating in a research report on Thursday, November 28th.

In other Genus news, insider Lysanne Gray sold 1,298 shares of the business’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of GBX 2,858 ($37.34), for a total transaction of £37,096.84 ($48,473.59). Also, insider Dan Hartley sold 1,191 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of GBX 3,110 ($40.64), for a total transaction of £37,040.10 ($48,399.45). In the last ninety days, insiders have sold 22,851 shares of company stock worth $67,205,592.

Shares of Genus stock opened at GBX 3,166 ($41.37) on Friday. The firm has a market capitalization of $2.07 billion and a P/E ratio of 266.05. Genus has a 52 week low of GBX 2,122 ($27.73) and a 52 week high of GBX 3,215.59 ($42.02). The company has a quick ratio of 1.19, a current ratio of 2.01 and a debt-to-equity ratio of 21.92. The firm’s 50 day moving average is GBX 3,015.56 and its two-hundred day moving average is GBX 2,765.22.

The company also recently declared a dividend, which was paid on Friday, November 29th. Investors of record on Thursday, November 7th were paid a dividend of GBX 18.80 ($0.25) per share. This represents a yield of 0.68%. The ex-dividend date of this dividend was Thursday, November 7th. This is an increase from Genus’s previous dividend of $8.90. Genus’s dividend payout ratio (DPR) is currently 2.35%.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Article: Options Trading – Understanding Strike Price

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.